Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Pharmacol Res. 2020 May 11;158:104847. doi: 10.1016/j.phrs.2020.104847

Table 1.

Comparison of the PS viability inhibitory effects (IC50) against the hormone-dependent BC cell lines.

PS 24 h 48 h 72 h
BT-474 (IC50) 260.83 μM 98.88 μM 93.64 μM
T47D (IC50) 267.48 μM 120.92 μM 113.08 μM